NIH Provides $5.3 Million Grant to Study Down Syndrome
The first clinical trial for Down syndrome regression disorder is being funded by a five-year $5.3 million grant.
HHS Issues Bulletin to Highlight Online Tracking Technology Obligations Under HIPAA Rules
The Office for Civil Rights issued a bulletin to highlight the obligations of the Health Insurance Portability and Accountability Act of 1996 on covered entities and business associates when using online tracking technologies.
$245 Million Awarded by HHS to Support Youth Mental Health
The U.S. Department of Health and Human Services has awarded nearly $245 million in Bipartisan Safer Communities Act funding to support the integration of mental health training into the training of primary care clinicians.
HHS Invests $13 Million to Grow and Strengthen the Nursing Workforce
The U.S. Department of Health and Human Services has awarded $13 million to bolster nursing education and training to grow the nursing workforce and improve access to nursing education.
Post-AMI Infusion of Human Apolipoprotein A-1 (CSL112) Strongly Boosts Impaired Cholesterol Efflux Capacity
Infusion of CSL112, an investigational human plasma-derived apolipoprotein A-1 formulated with phosphatidylcholine, rapidly and strongly elevates impaired cholesterol efflux capacity following acute myocardial infarction.
IVIG May Improve Survival in Patients with Acute Exacerbation of Fibrotic Idiopathic Interstitial Pneumonia
Investigators have found that intravenous immune globulin may have a positive effect on acute exacerbation of fibrotic idiopathic interstitial pneumonias.
HHS Releases New Reports on Positive Impact of Inflation Reduction Act on Prescription Drug Prices
The U.S. Department of Health and Human Services released two new reports that illustrate the urgency of addressing skyrocketing prescription drug costs in the U.S.
Report Released on Chronic Diseases and Related Risk Factors
The U.S. Centers for Disease Control and Prevention released the 2021 data from the Behavioral Risk Factor Surveillance System, which are now available through CDC’s easy-to-use web-based tool.
HHS Launches a National Biotechnology and Biomanufacturing Initiative
The U.S. Department of Health and Human Services has launched a National Biotechnology and Biomanufacturing Initiative to help drive research and development.
First Once-Daily Oral Plaque Psoriasis Drug Approved by FDA
The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib), a once-daily oral pill by Bristol Myers Squibb, for adults who have plaque psoriasis (a chronic, systemic, immune-mediated disease) severe enough to make them candidates for systemic therapy and phototherapy.
